<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04531020</url>
  </required_header>
  <id_info>
    <org_study_id>KDAR FN Brno 2020/10</org_study_id>
    <nct_id>NCT04531020</nct_id>
  </id_info>
  <brief_title>Incidence of Emergence Delirium in the PACU</brief_title>
  <acronym>PACUDEL</acronym>
  <official_title>Incidence of Emergence Delirium in the PACU: Prospective Observational Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brno University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence delirium (ED) is serious complication in the postoperative period in paediatric&#xD;
      anaesthesia, reported incidence is 20-60%. It is characterized by psychomotor and perception&#xD;
      disorder with excitation of paediatric patients. Emergence delirium has impact on morbidity&#xD;
      and even on mortality of paediatric patients in the postoperative period.&#xD;
&#xD;
      The potential risk factors for ED development include sevoflurane, which is the dominant&#xD;
      anaesthetic agent used in the paediatric patients, and which is actually the only inhalation&#xD;
      agent used for inhalation anaesthesia induction. The incidence of ED is higher in&#xD;
      postoperative period, for example in the Post-anaesthesia Care Unit - PACU. Patients with ED&#xD;
      are at higher risk of psychomotor anxiety, agitation, unintentional extraction of intravenous&#xD;
      cannula, and nausea and vomiting. For the therapy of ED propofol, midazolam and eventually&#xD;
      ketamine in a reduced dosage are used.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the approval of the study by the Ethics Committee of the University hospital Brno and&#xD;
      registration of the protocol at clinicaltrials.gov, the incidence of emergence delirium (ED)&#xD;
      using PAED, WATCHA and Richmond agitation and sedation scale (RASS) score in patients&#xD;
      hospitalized in the post-anaesthesia care unit (PACU) after general anaesthesia, in the&#xD;
      Departement of paediatric anaesthesia and intensive care unit, University Hospital Brno in&#xD;
      the term from 1.9.2020 until 30.6.2021 will be measured.&#xD;
&#xD;
      Paediatric Emergence Delirium (PAED) score, WATCHA score and Richmond agitation and sedation&#xD;
      scale (RASS) will be measured in 0., 5., 10., 15., and 20. minute after PACU admission and&#xD;
      after obtaining RASS ≥ - 2 . Emergence delirium is defined as PAED score above 10 points. In&#xD;
      the case of ED development, the duration of ED will be measured as well as the number of&#xD;
      therapeutic interventions and the cumulative dose of administered sedatives. The average&#xD;
      PAED, WATCHA, RASS scale will be reported, the incidence of postoperative nausea and vomiting&#xD;
      (PONV) and the cumulative dose of administered antiemetics, the type of anaesthesia induction&#xD;
      (inhalation vs. intravenous), type of anaesthesia (TIVA, combined, inhalational), length of&#xD;
      the surgery, type of the surgery will be reported.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of emergence delirium</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The incidence of emergence delirium, defined as PAED score above 10 points and/or WATCHA score over 2 and or RASS over 1 minimally in one of the measurements. All measurements will be measured in 0., 5., 10., 15., and 20. minute after PACU admission. The first measurement (T0) will be intiated after first obtaining RASS over -2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The duration of ED</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The cumulative duration of ED will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average PAED score</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The average PAED score at PACU will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The need for pharmacology intervention incidence</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The need for pharmacology intervention - defined by the number of therapeutic interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative nausea and vomiting (PONV)</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>incidence of postoperative nausea and vomiting (PONV) defined by the cumulative dose of administered antiemetics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of anaesthesia induction (inhalation vs. intravenous)</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>type of anaesthesia induction (inhalation vs. intravenous) will be evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of anaesthesia (TIVA, combined, inhalational)</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>type of anaesthesia (TIVA, combined, inhalational) will be evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of the surgery</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>length of the surgery will be evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of the surgery</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>type of the surgery will be evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative dose of administered sedatives</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>the cumulative dose of administered sedatives</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average WATCHA score</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The average WATCHA score at PACU will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average RASS score</measure>
    <time_frame>up to 60 minutes after PACU admission</time_frame>
    <description>The average RASS score at PACU will be measured</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Emergence Delirium</condition>
  <arm_group>
    <arm_group_label>Patients at PACU</arm_group_label>
    <description>Patients undergoing elective surgical or diagnostic intervention admitted to PACU after postanaesthesia recovery</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PAED measurement</intervention_name>
    <description>The incidence of emergence delirium, defined as PAED score above 10 points minimally in one of the PAED score measurements. PAED score will be measured in 0., 5., 10., 15., and 20. minute after PACU admission.</description>
    <arm_group_label>Patients at PACU</arm_group_label>
    <other_name>PAED score measurement at PACU</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients after general anaesthesia hospitalized in the PACU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients after general anaesthesia hospitalized in the PACU in the term rom 1.9.2020&#xD;
             until 30.6.2021.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients in the age from 0 to 1 month.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>19 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Petr Štourač, prof. MD., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of medicince Masaryk University and University Hospital Brno</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jozef Klučka, assoc.prof.MD., Ph.D.</last_name>
    <phone>+420532234696</phone>
    <email>jozoklucka@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eva Klabusayova, MD.</last_name>
    <phone>+420532234693</phone>
    <email>klabusayova.eva@fnbrno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Brno</name>
      <address>
        <city>Brno</city>
        <state>Česká Republika</state>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jozef Klučka, assoc.prof.MD.Ph.D.</last_name>
      <phone>+420532234696</phone>
      <email>klucka.jozef@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Eva Klabusayova, MD.</last_name>
      <phone>+420532234693</phone>
      <email>klabusayova.eva@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brno University Hospital</investigator_affiliation>
    <investigator_full_name>Petr Štourač, MD</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Emergence delirium</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>Paediatric patient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

